Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia

Ester Maria Orlandi, Chiara Elena, Elisa Bono

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalLeukemia and Lymphoma
DOIs
Publication statusAccepted/In press - Nov 28 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this